Some of the stocks that may grab investor focus today are:
- Shares of Kate Spade & Co (NASDAQ: KATE) jumped over 23 percent on Wednesday amid M&A speculation. The Wall Street Journal reported that Kate Spade is exploring a sale of itself due to pressure from Caerus Investors, an activist investment firm. Kate Spade shares rose 0.39 percent to $17.93 in the after-hours trading session.
- Shares of Fortress Biotech Inc (NASDAQ: FBIO) jumped around 50 percent in after-hours trading after the company disclosed that a patient case study from the Phase 1 clinical trial of MB-101 for the treatment of glioblastoma will be published in the New England Journal of Medicine. Fortress Biotech shares surged 49.78 percent to $3.43 in the after-hours trading session.
- AppDynamics, Inc. disclosed that it has filed for an initial public offering of up to $100 million. The company applied to list on the NASDAQ under the ticker “APPD.”
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
- Sprint Corp (NYSE: S) CEO Marcelo Claure confirmed commitment to create or bring back to America 5,000 jobs. Sprint shares rose 0.46 percent to $8.76 in after-hours trading.
- Interpace Diagnostics Group Inc (NASDAQ: IDXG) reported a 1-for-10 reverse split. Interpace Diagnostics shares tumbled 90.27 percent to $0.73 in the after-hours trading session.
- Mylan NV (NASDAQ: MYL) reported the launch of generic Zovia tablets. Mylan shares gained 1.10 percent to $37.62 in after-hours trading.